Skip to main content
Haemonetics Corporation (HAE)
NYSE: HAE · IEX Real-Time Price · USD
84.08
-0.57 (-0.67%)
At close: May 31, 2024, 4:00 PM
84.94
+0.86 (1.02%)
After-hours: May 31, 2024, 7:52 PM EDT

Haemonetics Revenue

In the fiscal year ending March 30, 2024, Haemonetics had annual revenue of $1.31B with 12.01% growth. Revenue in the quarter ending March 30, 2024 was $343.29M with 12.77% year-over-year growth.

Revenue (ttm)
$1.31B
Revenue Growth
+12.01%
P/S Ratio
3.27
Revenue / Employee
$357,959
Employees
3,657
Market Cap
4.27B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 30, 20241.31B140.40M12.01%
Apr 1, 20231.17B175.46M17.67%
Apr 2, 2022993.20M122.73M14.10%
Apr 3, 2021870.46M-118.02M-11.94%
Mar 28, 2020988.48M20.90M2.16%
Mar 30, 2019967.58M63.66M7.04%
Mar 31, 2018903.92M17.81M2.01%
Apr 1, 2017886.12M-22.72M-2.50%
Apr 2, 2016908.83M-1.54M-0.17%
Mar 28, 2015910.37M-28.14M-3.00%
Mar 29, 2014938.51M46.52M5.22%
Mar 30, 2013891.99M164.15M22.55%
Mar 31, 2012727.84M51.15M7.56%
Apr 2, 2011676.69M31.26M4.84%
Apr 3, 2010645.43M47.55M7.95%
Mar 28, 2009597.88M81.44M15.77%
Mar 29, 2008516.44M66.83M14.86%
Mar 31, 2007449.61M29.87M7.12%
Apr 1, 2006419.73M36.14M9.42%
Apr 2, 2005383.60M19.37M5.32%
Apr 3, 2004364.23M27.27M8.09%
Mar 29, 2003336.96M16.99M5.31%
Mar 30, 2002319.97M26.11M8.88%
Mar 31, 2001293.86M13.25M4.72%
Apr 1, 2000280.61M-3.90M-1.37%
Apr 3, 1999284.51M-1.25M-0.44%
Mar 28, 1998285.76M-17.25M-5.69%
Mar 29, 1997303.01M26.54M9.60%
Mar 30, 1996276.47M14.05M5.36%
Apr 1, 1995262.42M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Select Medical Holdings 6.79B
Oscar Health 6.54B
Perrigo Company 4.56B
Alkermes 1.73B
RadNet 1.66B
Integer Holdings 1.63B
TransMedics Group 296.92M
CRISPR Therapeutics AG 271.71M
Revenue Rankings

HAE News

More News